期刊文献+

慢性阻塞性肺疾病1年内再入院危险因素分析 被引量:12

Clinical research of risk factors contributing to one-year readmission of COPD patients
原文传递
导出
摘要 目的分析COPD1年内再入院的危险因素。方法本实验为前瞻性临床研究,研究对象为2007-2008年诊断为COPD的住院患者.实际随访137例,其中男性106例,女性31例。入组时基线平均年龄76岁(最小年龄72岁,最大年龄81岁):平均体质量指数21.39kg/m^2;平均FEV19/pred为46%(最小29.5%.最大57%)。入组前1年内因AECOPD住院1次、2次及3次以上分别为32例、19例和14例。出院骨平均随访1年。主要研究终点是出院后1年内再入院情况。结果多因素Logistic回归分析结果显示,在对其他因素进行校正岳。既往住院史、C反应蛋白≥3mg/L和PaO2≤60mmHg与再入院相关,OR值分别为5.820、4.940和5.134(P〈0.05)。结论既住1年内住院史、较高的C反应蛋白水平及低氧血症与出院1年内再入院相关。 Objective To investigate the risk factors that contributing to one-year readmission of COPD. Methods This is a prospective cohort study. A total of 137 COPD in patients were enlolled between 2007 and 2008,with 106 male and 31 female. The average BMI at 21.39 kg/m^2,and the average FEV1% pred was 46 (29.5 % to 57 % ). 32,19 and 14 patients admitted because of AECOPD for once, twice or 3 times separately in the last one year. Patients were followed Lip for an average of one year. Results l.ogistic regression revealed that,after adjusted with other factors, the history of COPD admission in the last year, CRP≥3 mg/L and PaO2≤60 mmHg were the main risk factors contribuling to one year readmission ( OR = 5. 820,4. 940 and 5. 134 separately, P 〈0.05). Conclusions Past history of COPD admission in last 1 year,high CRP level and hypoxemia associated with 1 year readmission.
出处 《国际呼吸杂志》 2014年第7期500-503,共4页 International Journal of Respiration
关键词 慢性阻塞性肺疾病急性加重 再入院 C反应蛋白 低氧血症 Acute exacerbation of chronic obstructive pulmonary disease Readmission C- reactive protein Hypoxemia
  • 相关文献

参考文献16

  • 1Brusse-Keizer M, van der Palen J,van der Valk P, el al. Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease[J]. Clin Respir J,2011,5:227- 234.
  • 2中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修汀版)[J].中华内科杂志,2007.46:254-261.
  • 3Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators ( Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) [J]. Am J Res.oir ('rit cre Med, 1996. 154(4 Pt 1)=959- 967.
  • 4Agusti A, Calverley PM, Celli B. et al. Characterisation of COPD heterogeneity in the ECLIPSI cohort[J]. Respir Res, 2010,11:122.
  • 5Hurst JR. Vestbo J. Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease[J]. N EnglJ Med.2010,363:l128- 1138.
  • 6Donaldson GC,Seemungal TA,Patel lS. et al. l,ongitudinal changes in the Nature, severity and frequency of C()PI) exaeerbations[J]. Eur Respir J.2003,22:931-936.
  • 7Aaron SD,Donaldson G(7,Whitmore GA,et al. Time course and pattern of ('()PD exacerbation onset[J]. Thorax.2012. 67:238 243.
  • 8I,au A(',Yam I,Y,Poon E. Hospital re admission in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Respir Med,2001,95=876- 884.
  • 9de Torres JP, Cordoba-I,anus E, 1,6pez-Aguilar 4", el al. C reactive protein levels and clinically imporlant predictive outcomes in stable C()PI) patients[J]. Eur Respir J.2006. 27:902-907.
  • 10孙国磊,曹洁,董丽霞,陈宝元.慢性阻塞性肺疾病急性加重期患者血清前降钙素原及C反应蛋白水平的变化及一年的随访研究[J].国际呼吸杂志,2013,33(7):513-517. 被引量:20

二级参考文献18

  • 1常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3许建英,李筱妍,杜永成,杨丽莉,王淑峰,王红.慢性阻塞性肺疾病急性加重期病原学与肺功能关系的研究[J].中国呼吸与危重监护杂志,2007,6(2):88-92. 被引量:21
  • 4Lacoma A, Prat C, Andreo F,et al. Value of procalcitonin C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis,2011,6:157-169.
  • 5Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J, 2003 21,347-360.
  • 6Hill A, Gompertz S, Stockley R. Factors influencing airway inflammation in chronic obstructive pulmonary disease Thorax,2000,55:970-977.
  • 7Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 1998,92 : 664-667.
  • 8Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized controlled trial comparing procalcitonin-guidance with standard therapy. Chest, 2007,131 : 9-19.
  • 9Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax, 2006,61: 250-258.
  • 10Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin,C-reactive protein, and procalcitonin prognostic biomarkers in acute exacerbation of COPD. Chest,2007,131 1058-1067.

共引文献20

同被引文献103

引证文献12

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部